Polycythemia Vera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Polycythemia Vera Pipeline Drugs Market Overview
Polycythemia Vera pipeline market research report provides comprehensive information on the therapeutics under development for Polycythemia Vera, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Polycythemia Vera and features dormant and discontinued projects.
Key Targets in the Polycythemia Vera Pipeline Market
The key targets in the Polycythemia Vera pipeline market are Tyrosine Protein Kinase JAK2, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Bcl 2 Like Protein 1, Bcl 2 Like Protein 2, Hepcidin, and Histone Deacetylase 1. Tyrosine Protein Kinase JAK2 has the highest pipeline products.
Polycythemia Vera Pipeline Market, by Targets
For more target insights, download a free report sample
Key MoA in the Polycythemia Vera Pipeline Market
The types of key MoA in the Polycythemia Vera pipeline market are Tyrosine Protein Kinase JAK2 Inhibitor, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, Bcl 2 Like Protein 1 Inhibitor, Bcl 2 Like Protein 2 Inhibitor, Histone Deacetylase 1 Inhibitor, Histone Deacetylase 2 Inhibitor, and Transmembrane Protease Serine 6 Inhibitor. Tyrosine Protein Kinase JAK2 Inhibitor has the maximum number of pipeline products.
Polycythemia Vera Pipeline Market, by MoA
For more MoA insights, download a free report sample
Key RoA in the Polycythemia Vera Pipeline Market
The types of key RoA in the Polycythemia Vera pipeline market are subcutaneous, oral, intravenous, intramuscular, topical, intradermal, and intravenous drip. Subcutaneous has the majority number of pipeline products.
Polycythemia Vera Pipeline Market, by RoA
For more RoA insights, download a free report sample
Key Molecule Types in the Polycythemia Vera Pipeline Market
The key molecule types in the Polycythemia Vera pipeline market are small molecule, recombinant protein, subunit vaccine, peptide, antisense oligonucleotide, antisense RNAi oligonucleotide, monoclonal antibody, and synthetic peptide. Small molecule type has the highest number of pipeline products.
Polycythemia Vera Pipeline Market, by Molecule Types
For more molecule type insights, download a free report sample
Key Companies in the Polycythemia Vera Pipeline Market
In the Polycythemia Vera pipeline market the key companies in are Protagonist Therapeutics Inc, Ascentage Pharma Group International, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corp, Hangzhou Bensheng Pharmaceutical Co Ltd, Imago BioSciences Inc, and Ionis Pharmaceuticals Inc. Protagonist Therapeutics Inc has the maximum number of pipeline products.
Polycythemia Vera Pipeline Market, by Companies
To know more about companies, download a free report sample
Market report overview
Key targets | Tyrosine Protein Kinase JAK2, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Bcl 2 Like Protein 1, Bcl 2 Like Protein 2, Hepcidin, and Histone Deacetylase 1 |
Key MoA | Tyrosine Protein Kinase JAK2 Inhibitor, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, Bcl 2 Like Protein 1 Inhibitor Bcl 2 Like Protein 2 Inhibitor, Histone Deacetylase 1 Inhibitor, Histone Deacetylase 2 Inhibitor, and Transmembrane Protease Serine 6 Inhibitor |
Key RoA | Subcutaneous, Oral, Intravenous, Intramuscular, Topical, Intradermal, and Intravenous Drip |
Key Molecule Types | Small Molecule, Recombinant Protein, Subunit Vaccine, Peptide, Antisense Oligonucleotide, Antisense RNAi Oligonucleotide, Monoclonal Antibody, and Synthetic Peptide |
Key Companies | Protagonist Therapeutics Inc, Ascentage Pharma Group International, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corp, Hangzhou Bensheng Pharmaceutical Co Ltd, Imago BioSciences Inc, and Ionis Pharmaceuticals Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Polycythemia Vera (Oncology)
- The pipeline guide reviews pipeline therapeutics for Polycythemia Vera (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities
- The pipeline guide reviews key companies involved in Polycythemia Vera (Oncology) therapeutics and enlists all their major and minor projects
- The pipeline guide evaluates Polycythemia Vera (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects
- The pipeline guide reviews latest news related to pipeline therapeutics for Polycythemia Vera (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies
- Recognize emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Find and recognize significant and varied types of therapeutics under development for Polycythemia Vera (Oncology)
- Classify potential new clients or partners in the target demographic
- Develop tactical initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics
- Formulate corrective measures for pipeline projects by understanding Polycythemia Vera (Oncology) pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline
Ascentage Pharma Group International
F. Hoffmann-La Roche Ltd
Fujifilm Holdings Corp
Hangzhou Bensheng Pharmaceutical Co Ltd
Imago BioSciences Inc
Incyte Corp
IO Biotech Inc
Ionis Pharmaceuticals Inc
Italfarmaco SpA
Kartos Therapeutics Inc
Merganser Biotech Inc
PharmaEssentia Corp
Protagonist Therapeutics Inc
Shanghai Xunhe Pharmaceutical Technology Co Ltd
Silence Therapeutics Plc
Sino Biopharmaceutical Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Polycythemia Vera pipeline market?
The key targets in the Polycythemia Vera pipeline market are Tyrosine Protein Kinase JAK2, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Bcl 2 Like Protein 1, Bcl 2 Like Protein 2, Hepcidin, and Histone Deacetylase 1.
-
What are the types of MoA in the Polycythemia Vera pipeline market?
The types of key MoA in the Polycythemia Vera pipeline market are Tyrosine Protein Kinase JAK2 Inhibitor, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, Bcl 2 Like Protein 1 Inhibitor Bcl 2 Like Protein 2 Inhibitor, Histone Deacetylase 1 Inhibitor, Histone Deacetylase 2 Inhibitor, and Transmembrane Protease Serine 6 Inhibitor.
-
What are the types of key RoA in the Polycythemia Vera pipeline market?
The types of key RoA in the Polycythemia Vera pipeline market are subcutaneous, oral, intravenous, intramuscular, topical, intradermal, and intravenous drip.
-
What are the key molecule types in the Polycythemia Vera pipeline market?
In the Polycythemia Vera pipeline market, the key molecule types in are small molecule, recombinant protein, subunit vaccine, peptide, antisense oligonucleotide, antisense RNAi oligonucleotide, monoclonal antibody, and synthetic peptide.
-
What are the key companies in the Polycythemia Vera pipeline market?
The leading companies in the Polycythemia Vera pipeline market are Protagonist Therapeutics Inc, Ascentage Pharma Group International, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corp, Hangzhou Bensheng Pharmaceutical Co Ltd, Imago BioSciences Inc, and Ionis Pharmaceuticals Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.